Trial Profile

Prospective, Randomized, Double-Blind, Multicenter phase II trial comparing the efficacy of chemotherapy with cisplatin and gemcitabine plus sorafenib (BAY 43-9006) versus gemcitabine plus cisplatin, and placebo in the treatment of locally advanced Respectively. Metastatic urothelial AB 31/05 - RUTTE 204 - SUSE.

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 28 May 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

15 Feb 2012 Company (Bayer HealthCare) added as trial sponsor/affiliate as reported by German Clinical Trials Register record.
15 Feb 2012 New source identified and integrated (German Clinical Trials Register; DRKS00003397).
07 Sep 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com